We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$712B
AUM Growth
+$31.8B
Cap. Flow
+$2.48B
Cap. Flow %
0.35%
Top 10 Hldgs %
21.18%
Holding
2,600
New
72
Increased
1,394
Reduced
949
Closed
59

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$2.27B
2
LLY icon
Eli Lilly
LLY
+$1.64B
3
NVDA icon
NVIDIA
NVDA
+$1.59B
4
RHT
Red Hat Inc
RHT
+$1.55B
5
BKNG icon
Booking.com
BKNG
+$1.12B

Sector Composition

Rank Sector Weight
1 Technology 18.88%
2 Healthcare 16.96%
3 Financials 13.79%
4 Consumer Discretionary 13.57%
5 Industrials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRB icon
2426
Seres Therapeutics
MCRB
$47.4M
$167K ﹤0.01%
2,600
-1,919
-42% -$182K
INSG icon
2427
Inseego
INSG
$82.6M
$166K ﹤0.01%
3,464
+84
+2% +$3.95K
ACOR
2428
DELISTED
Acorda Therapeutics
ACOR
$161K ﹤0.01%
174
+1
+0.6% +$1.23K
SPTN
2429
DELISTED
SpartanNash
SPTN
$160K ﹤0.01%
13,681
-633,836
-98% -$9.04M
CYH icon
2430
Community Health Systems
CYH
$410M
$158K ﹤0.01%
59,040
+256
+0.4% +$808
MBT
2431
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$157K ﹤0.01%
16,900
+2,700
+19% +$22K
ARAY icon
2432
Accuray
ARAY
$33.4M
$156K ﹤0.01%
40,424
+100
+0.2% +$404
SNDA icon
2433
Sonida Senior Living
SNDA
$1.88B
$156K ﹤0.01%
2,067
-29
-1% -$1.82K
EVH icon
2434
Evolent Health
EVH
$471M
$153K ﹤0.01%
19,211
+310
+2% +$3.67K
DGII icon
2435
Digi International
DGII
$3.23B
$152K ﹤0.01%
12,009
AMKR icon
2436
Amkor Technology
AMKR
$13.8B
$150K ﹤0.01%
20,116
+600
+3% +$4.7K
WT icon
2437
WisdomTree
WT
$3.44B
$149K ﹤0.01%
24,199
+620
+3% +$4.21K
JCP
2438
DELISTED
J.C. Penney Company, Inc.
JCP
$148K ﹤0.01%
129,625
+700
+0.5% +$831
BREW
2439
DELISTED
Craft Brew Alliance, Inc.
BREW
$147K ﹤0.01%
10,513
+38
+0.4% +$543
BBBY
2440
Bed Bath & Beyond
BBBY
$403M
$146K ﹤0.01%
14,338
+110
+0.8% +$1.03K
FTR
2441
DELISTED
Frontier Communications Corp.
FTR
$145K ﹤0.01%
82,745
+200
+0.2% +$408
IDT icon
2442
IDT Corp
IDT
$1.63B
$143K ﹤0.01%
15,059
+314
+2% +$2.31K
DALN
2443
DELISTED
DallasNews
DALN
$142K ﹤0.01%
9,646
GME icon
2444
GameStop
GME
$8.32B
$141K ﹤0.01%
103,420
+800
+0.8% +$1.56K
MRAM icon
2445
Everspin Technologies
MRAM
$415M
$132K ﹤0.01%
20,300
KA
2446
DELISTED
Kineta, Inc. Common Stock
KA
$132K ﹤0.01%
964
-4
-0.4% -$621
TUSK icon
2447
Mammoth Energy Services
TUSK
$158M
$131K ﹤0.01%
19,078
+337
+2% +$4.28K
LTHM
2448
DELISTED
Livent Corporation
LTHM
$130K ﹤0.01%
18,775
+355
+2% +$3.19K
AFI
2449
DELISTED
Armstrong Flooring, Inc.
AFI
$130K ﹤0.01%
13,236
SWBI icon
2450
Smith & Wesson
SWBI
$636M
$128K ﹤0.01%
18,465
+130
+0.7% +$921

Similar funds

T. Rowe Price Associates's Q2 2019 Portfolio in Review

As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
  • T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
  • T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
  • T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
  • T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
  • T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.